top of page
About Us
Our commitment
Letter from the CEO
Team
Science & Pipeline
Circular RNA
Mental health
Neurological care
Alzheimer's Disease
Alzheimer's Disease for Biopharma
Our Pipeline
Products
MindLight
News
Contact
All posts
Press releases
News
Circular Genomics Joins Lilly Gateway Labs in San Diego to Develop Its Best-In-Class Circular RNA Platform for the Diagnosis and Prognosis of Alzheimer's Disease
Press releases
Mar 17, 2025
Circular Genomics Announces Launch of MindLightâ„¢, the First SSRI Antidepressant Response Test Using Brain-Derived Biomarkers
Press releases
Sep 16, 2024
Circular Genomics Announces New Research Demonstrating Accuracy of circRNA-based Test for Predicting Response to SSRI Antidepressant Treatment
Press releases
May 7, 2024
bottom of page
